ALQGC — Quantum Genomics SA Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Quantum Genomics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 11.2 | 27.2 | 13.6 | 10.4 | 3.55 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.01 | 3.85 | 3.57 | 12.9 | 0.119 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 14.2 | 33.5 | 21.4 | 23.4 | 3.69 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.027 | 0.027 | 0.03 | 0.023 | 0.008 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 15.1 | 35 | 22.6 | 23.7 | 3.75 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.95 | 6.64 | 10.2 | 19.4 | 1.35 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.24 | 7.1 | 11 | 20 | 3.31 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 10.9 | 27.9 | 11.6 | 3.65 | 0.437 |
Total Liabilities & Shareholders' Equity | 15.1 | 35 | 22.6 | 23.7 | 3.75 |
Total Common Shares Outstanding |